40 results
Thumbnail

D1.200 - Allergenicity of profilin isoallergens from Korean melon

Thumbnail

D1.201 - Safety and Effectiveness of Subcutaneous Immunotherapy with Non-Homologous Aeroallergen Mixtures: A Real-World Study

Thumbnail

D1.202 - Comparison of 2 different medication scores for the calculation of the Combined Symptom and Medication Score – EAACI versus paediatric medication in Germany

Thumbnail

D1.203 - Prospective study to investigate the symptom profile and medication consumption of patients with seasonal allergic rhinitis/rhinoconjunctivitis who are interested in allergen-specific immunotherapy

Thumbnail

D1.206 - Local allergic rhinitis to birch pollen: a case of transient IgE+ plasmablast detection and successful sublingual immunotherapy

Thumbnail

D1.207 - Molecular Patterns and Age-Related Evolution of Pollen Sensitization in Children

Thumbnail

D1.213 - Staphylococcus aureus enterotoxins in allergic rhinitis: impact on disease severity and molecular sensitization profile

Thumbnail

D1.215 - Safety of subcutaneous immunotherapy with purified native protein Alt a 1, a major allergen of Alternaria alternata: 7-year real-world data

Thumbnail

D1.216 - AIT prescription drivers: a factor analysis of data from the CHOICE survey

Thumbnail

D1.217 - Reduction in healthcare resource utilization in pediatric patients treated with 300 IR liquid SLIT: a real‑world subanalysis from Spain and Italy

Thumbnail

D1.205 - Immunological characterization of recombinant Sal k 1 produced in Nicotiana benthamiana and potential immunomodulatory role of HSP90 in Salsola kali allergy

Thumbnail

D1.208 - Monocentric retrospective study of asthma prevalence among patients allergic to birch and grass pollens at Strasbourg University Hospital

Thumbnail

D1.214 - Analysis of the time to achieve a maintenance dose of tree pollen allergen in specific immunotherapy of allergic rhinitis

Thumbnail

D2.449 - Patients with Inadequately Controlled CRSwNP and Blood Eosinophil Count ≥150 cells/µL Experience Benefit with Depemokimab: An Analysis of Data from the Integrated ANCHOR-1/-2 Studies

Thumbnail

D2.447 - Phenotyping of Chronic T2 Inflammatory Diseases of the Nose and Paranasal Sinuses and the Algorithm for Biologic Therapy Selection

Thumbnail

D2.448 - Recommendations on Patient Education for Biological Therapy in CRSwNP – An EAACI Position Paper

Thumbnail

D2.450 - EUFOREA/EPOS Criteria Applied to a Diverse CRSwNP Cohort: Post Hoc Findings from Twice-Yearly depemokimab ANCHOR-1/-2 trials

Thumbnail

D2.451 - Real-life upper and lower airway outcomes of long-term dupilumab treatment in patients with severe chronic rhinosinusitis with nasal polyps

Thumbnail

D2.452 - Real-World Trends in the Epidemiology and Burden of Chronic Rhinosinusitis with Nasal Polyps Over Time in Germany Reveal Increasing Prevalence and Low Biologic Use

Thumbnail

D2.453 - Olfactory outcomes of dupilumab in patients with CRSwNP: A real-world prospective study